Suscripción a Biblioteca: Guest
Critical Reviews™ in Biomedical Engineering

Publicado 6 números por año

ISSN Imprimir: 0278-940X

ISSN En Línea: 1943-619X

SJR: 0.262 SNIP: 0.372 CiteScore™:: 2.2 H-Index: 56

Indexed in

Novel Approaches of CRISPR-Cas Technology in Airway Diseases

Volumen 48, Edición 3, 2020, pp. 169-176
DOI: 10.1615/CritRevBiomedEng.2020034594
Get accessGet access

SINOPSIS

Clustered regularly interspaced palindromic repeats (CRISPR) technique plays a vital role in preclinical modelling of many respiratory diseases. Diseases such as chronic obstructive pulmonary disease (COPD), asthma, acute tracheal bronchitis, pneumonia, tuberculosis, lung cancer, and influenza infection continue to significantly impact human health. CRISPR associated (Cas) proteins, isolated from the immune system of prokaryotes, are one component of a very useful technique to manipulate gene sequences or editing and gene expression with significant implications for respiratory research in the field of molecular biology. CRISPR technology is a promising tool that is easily adaptable for specific editing of DNA sequences of interest with a goal towards modifying or eliminating gene function. Among its many potential applications, CRISPR can be applied to correcting genetic defects as well as for therapeutic approaches for treatment. This review elucidates recent advances in CRISPR-Cas technology in airway diseases.

PALABRAS CLAVE: COPD, asthma, chronic bronchitis
REFERENCIAS
  1. Makarova KS, Haft DH, Barrangou R, Brouns SJJ, Charpentier E, Horvath P, Moineau S, Mojica FJM, Wolf YI, Yakunin AF, van der Oost J, Koonin EV. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol. 2011 ;9(6):467 77. PubMed PMID: 21552286. Pubmed Central PMCID: 3380444. .

  2. Cho SW, Kim S, Kim JM, Kim JS. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol. 2013;31(3):230-2. PubMed PMID: 23360966. .

  3. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819-23. PubMed PMID: 23287718. Pubmed Central PMCID: 3795411. .

  4. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816-21. PubMed PMID: 22745249. Pubmed Central PMCID: 6286148. .

  5. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. RNA-guided human genome engineering via Cas9. Science. 2013;339(6121):823-6. PubMed PMID: 23287722. Pubmed Central PMCID: 3712628. .

  6. Jansen R, Embden JD, Gaastra W, Schouls LM. Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol. 2002;43(6): 1565-75. PubMed PMID: 11952905. .

  7. Haft DH, Selengut J, Mongodin EF, Nelson KE. A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes. PLoS Comp Biol. 2005;1(6):e60. PubMed PMID: 16292354. Pubmed Central PMCID: 1282333. .

  8. Koonin EV, Makarova KS, Zhang F. Diversity, classification and evolution of CRISPR-Cas systems. Curr Opin Microbiol. 2017;37:67-78. PubMed PMID: 28605718. Pubmed Central PMCID: 5776717. .

  9. Koonin EV, Makarova KS. Origins and evolution of CRIS-PR-Cas systems. Philos Trans R Soc Lond B Biol Sci. 2019;374(1772):20180087. PubMed PMID: 30905284. Pubmed Central PMCID: 6452270. .

  10. Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, Barrangou R, Brouns SJ, Charpentier E, Haft DH, Horvath P, Moineau S, Mojica FJ, Terns RM, Terns MP, White MF, Yakunin AF, Garrett RA, van der Oost J, Backofen R, Koonin EV. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol. 2015;13(11):722-36. PubMed PMID: 26411297. Pubmed Central PMCID: 5426118. .

  11. Godde JS, Bickerton A. The repetitive DNA elements called CRISPRs and their associated genes: Evidence of horizontal transfer among prokaryotes. J Mol Evol. 2006;62(6):718-29. PubMed PMID: 16612537. .

  12. Wright AV, Nunez JK, Doudna JA. Biology and applications of CRISPR systems: Harnessing nature's toolbox for genome engineering. Cell. 2016;164(1-2):29-44. PubMed PMID: 26771484. .

  13. Gasiunas G, Barrangou R, Horvath P, Siksnys V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A. 2012;109(39):E2579-86. PubMed PMID: 22949671. Pubmed Central PMCID: 3465414. .

  14. Waryah CB, Moses C, Arooj M, Blancafort P. Zinc fingers, TALEs, and CRISPR systems: A comparison of tools for epigenome editing. Methods Mol Biol. 2018;1767:19-63. PubMed PMID: 29524128. .

  15. Cox DBT, Gootenberg JS, Abudayyeh OO, Franklin B, Kellner MJ, Joung J, Zhang F. RNA editing with CRIS-PR-Cas13. Science. 2017;358(6366):1019-27. PubMed PMID: 29070703. Pubmed Central PMCID: 5793859. .

  16. Oakes BL, Nadler DC, Savage DF. Protein engineering of Cas9 for enhanced function. Methods Enzymol. 2014;546:491-511. PubMed PMID: 25398355. Pubmed Central PMCID: 4641071. .

  17. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O'Don nell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pa- hari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA 3rd, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De Leon FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128. PubMed PMID: 23245604. .

  18. Vestbo J. COPD: Definition and phenotypes. Clin Chest Med. 2014;35(1):1-6. PubMed PMID: 24507832. .

  19. Montes de Oca M, Perez-Padilla R. Global initiative for chronic obstructive lung disease (GOLD)-2017: The alat perspective. Arch Bronconeumol. 2017;53(3):87-8. PubMed PMID: 28222935. .

  20. Kim EJ, Yoon SJ, Kim YE, Go DS, Jung Y. Effects of aging and smoking duration on cigarette smoke-induced COPD severity. J Korean Med Sci. 2019;34(Suppl 1):e90. PubMed PMID: 30923493. Pubmed Central PMCID: 6434146. .

  21. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K, Walsh BJ, Nicholson RC, Fairlie WD, Por SB, Robbins JM, Breit SN. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-P super-family. Proc Natl Acad Sci U S A. 1997;94(21):11514-9. PubMed PMID: 9326641. Pubmed Central PMCID: 23523. .

  22. Wu Q, Jiang D, Matsuda JL, Ternyak K, Zhang B, Chu HW. Cigarette smoke induces human airway epithelial senescence via growth differentiation factor 15 production. Am J Respir Cell Mol Biol. 2016;55(3):429-38. PubMed PMID: 27093475. .

  23. Chu HW, Rios C, Huang C, Wesolowska-Andersen A, Burchard EG, O'Connor BP, Fingerlin TE, Nichols D, Reynolds SD, Seibold MA. CRISPR-Cas9-mediated gene knockout in primary human airway epithelial cells reveals a proinflammatory role for MUC18. Gene Ther. 2015;22(10):822-9. PubMed PMID: 26043872. Pubmed Central PMCID: 4600011. .

  24. Stolzenburg LR, Harris A. Microvesicle-mediated delivery of miR-1343: Impact on markers of fibrosis. Cell Tiss Res. 2018;371(2):325-38. PubMed PMID: 29022142. Pubmed Central PMCID: 5809304. .

  25. Zhang YH, Wu LZ, Liang HL, Yang Y, Qiu J, Kan Q, Zhu W, Ma CL, Zhou XY. Pulmonary surfactant synthesis in miRNA-26a-1/miRNA-26a-2 double knockout mice gen-erated using the CRISPR/Cas9 system. Am J Transl Res. 2017;9(2):355-65. PubMed PMID: 28337265. Pubmed Central PMCID: 5340672. .

  26. Wang S, Samakovlis C. Grainy head and its target genes in epithelial morphogenesis and wound healing. Curr Top Dev Biol. 2012;98:35-63. PubMed PMID: 22305158. .

  27. Gao X, Bali AS, Randell SH, Hogan BL. GRHL2 coordinates regeneration of a polarized mucociliary epithelium from basal stem cells. J Cell Biol. 2015;211(3):669-82. PubMed PMID: 26527742. Pubmed Central PMCID: 4639861. .

  28. Unwalla HJ, Ivonnet P, Dennis JS, Conner GE, Salathe M. Transforming growth factor-P1 and cigarette smoke inhibit the ability of P2-agonists to enhance epithelial permeability. Am J Respir Cell Mol Biol. 2015;52(1):65-74. PubMed PMID: 24978189. Pubmed Central PMCID: 4370252. .

  29. Conner GE, Salathe M, Forteza R. Lactoperoxidase and hydrogen peroxide metabolism in the airway. Am J Respir Crit Care Med. 2002;166(12 Pt 2):S57-61. PubMed PMID: 12471090. Epub 2002/12/10.eng. .

  30. Conner GE, Wijkstrom-Frei C, Randell SH, Fernandez VE, Salathe M. The lactoperoxidase system links anion transport to host defense in cystic fibrosis. FEBS Lett. 2007;581(2):271-8. PubMed PMID: 17204267. Pubmed Central PMCID: 1851694. Epub 2007/01/06.eng. .

  31. Vaidyanathan S, Salahudeen AA, Sellers ZM, Bravo DT, Choi SS, Batish A, Le W, Baik R, de la O S, Kaushik MP, Galper N, Lee CM, Teran CA, Yoo JH, Bao G, Chang EH, Patel ZM, Hwang PH, Wine JJ, Milla CE, Desai TJ, Nayak JV, Kuo CJ, Porteus MH. High-efficiency, selection-free gene repair in airway stem cells from cystic fibrosis patients rescues CFTR function in differentiated epithelia. Cell Stem Cell. 2020;26(2): 161-71. PubMed PMID: 31839569. .

  32. Elborn JS. Personalised medicine for cystic fibrosis: Treating the basic defect. Eur Respir Rev. 2013;22(127):3-5. PubMed PMID: 23457158. .

  33. Clancy JP, Cotton CU, Donaldson SH, Solomon GM, Van-Devanter DR, Boyle MP, Gentzsch M, Nick JA, Illek B, Wallenburg JC, Sorscher EJ, Amaral MD, Beekman JM, Naren AP, Bridges RJ, Thomas PJ, Cutting G, Rowe S, Durmowicz AG, Mense M, Boeck KD, Skach W, Penland C, Joseloff E, Bihler H, Mahoney J, Borowitz D, Tuggle KL. CFTR modulator theratyping: Current status, gaps and future directions. J Cyst Fibros. 2019;18(1):22-34. PubMed PMID: 29934203. Pubmed Central PMCID: 6301143. .

  34. Castellani C, CFTR2 Team. CFTR2: How will it help care? Paediatr Respir Rev. 2013;14(Suppl 1):2-5. PubMed PMID: 23466340. .

  35. Marangi M, Pistritto G. Innovative therapeutic strategies for cystic fibrosis: Moving forward to CRISPR technique. Front Pharmacol. 2018;9:396. PubMed PMID: 29731717. Pubmed Central PMCID: 5920621. .

  36. Hollywood JA, Lee CM, Scallan MF, Harrison PT. Analysis of gene repair tracts from Cas9/gRNA double-stranded breaks in the human CFTR gene. Sci Rep. 2016;6:32230. PubMed PMID: 27557525. Pubmed Central PMCID: 4997560. .

  37. Kunzelmann K, Schwiebert EM, Zeitlin PL, Kuo WL, Stanton BA, Gruenert DC. An immortalized cystic fibrosis tracheal epithelial cell line homozygous for the AF508 CFTR mutation. Am J Respir Cell Mol Biol. 1993;8(5):522-9. PubMed PMID: 7683197. .

  38. Sanz DJ, Hollywood JA, Scallan MF, Harrison PT. Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA. PLoS One. 2017;12(9):e0184009. PubMed PMID: 28863137. Pubmed Central PMCID: 5581164. .

  39. Rosen BH, Chanson M, Gawenis LR, Liu J, Sofoluwe A, Zoso A, Engelhardt JF. Animal and model systems for studying cystic fibrosis. J Cyst Fibros. 2018;17(2S):S28-34. PubMed PMID: 28939349. Pubmed Central PMCID: 5828943. .

  40. Murdoch JR, Lloyd CM. Chronic inflammation and asthma. Mutat Res. 2010;690(1-2):24-39. PubMed PMID: 19769993. Epub 09/19.eng. .

  41. Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr. 2019;7:246. PubMed PMID: 31275909.eng. .

  42. Braman SS. The global burden of asthma. Chest. 2006; 130(1 Suppl):4S-12S. PubMed PMID: 16840363. Epub 2006/07/15.eng. .

  43. Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3:1. PubMed PMID: 28078100.eng. .

  44. Trevor JL, Chipps BE. Severe asthma in primary care: Identification and management. Am J Med. 2018;131(5):484-91. .

  45. Rabe KF, Schmidt DT. Pharmacological treatment of asthma today. Eur Respir J. 2001;18(34 Suppl):34s-40s. .

  46. Goodman MA, Moradi Manesh D, Malik P, Rothenberg ME. CRISPR/Cas9 in allergic and immunologic diseases. Expert Rev Clin Immunol. 2017;13(1):5-9. PubMed PMID: 27687572. Epub 10/24.eng. .

  47. Simon GC, Martin RJ, Smith S, Thaikoottathil J, Bowler RP, Barenkamp SJ, Chu HW. Up-regulation of MUC18 in airway epithelial cells by IL-13: Implications in bacterial adherence. Am J Respir Cell Mol Biol. 2011;44(5):606-13. PubMed PMID: 21239604. Pubmed Central PMCID: PMC3095981. Epub 2011/01/18.eng. .

  48. Chu HW, Rios C, Huang C, Wesolowska-Andersen A, Burchard EG, O'Connor BP, Fingerlin TE, Nichols D, Reynolds SD, Seibold MA. CRISPR-Cas9-mediated gene knockout in primary human airway epithelial cells reveals a proinflammatory role for MUC18. Gene Ther. 2015;22(10):822-9. .

  49. Lambert KA, Prendergast LA, Dharmage SC, Tang M, O'Sullivan M, Tran T, Druce J, Bardin P, Abramson MJ, Erbas B. The role of human rhinovirus (HRV) species on asthma exacerbation severity in children and adolescents. J Asthma. 2018;55(6):596-602. PubMed PMID: 29020463. Epub 2017/10/12.eng. .

  50. Watters K, Palmenberg AC. CDHR3 extracellular domains EC1-3 mediate rhinovirus C interaction with cells and as recombinant derivatives, are inhibitory to virus infection. PLoS Pathog. 2018;14(12):e1007477. .

  51. Everman JL, Sajuthi S, Saef B, Rios C, Stoner AM, Numata M, Hu D, Eng C, Oh S, Rodriguez-Santana J, Vladar EK, Voelker DR, Burchard EG, Seibold MA. Functional genomics of CDHR3 confirms its role in HRV-C infection and childhood asthma exacerbations. J Allergy Clin Immunol. 2019;144(4):962-71. .

  52. Buhl R, Garn H, Renz H. Allergen responses modified by a GATA3 DNAzyme. N Engl J Med. 2015;373(12):1176-7. PubMed PMID: 26376148. .

  53. Henriksson J, Chen X, Gomes T, Ullah U, Meyer KB, Miragaia R, Duddy G, Pramanik J, Yusa K, Lahesmaa R, Teichmann SA. Genome-wide CRISPR screens in T helper cells reveal pervasive crosstalk between activation and differentiation. Cell. 2019;176(4):882-96.e18. PubMed PMID: 30639098. Epub 01/10.eng. .

  54. Yang H, Li S. Transient receptor potential ankyrin 1 (TRPA1) channel and neurogenic inflammation in pathogenesis of asthma. Med Sci Monit. 2016;22:2917-23. PubMed PMID: 27539812.eng. .

  55. Caceres AI, Brackmann M, Elia MD, Bessac BF, del Camino D, D'Amours M, Witek JS, Fanger CM, Chong JA, Hayward NJ, Homer RJ, Cohn L, Huang X, Moran MM, Jordt SE. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc Natl Acad Sci US A. 2009;106(22):9099-104. PubMed PMID: 19458046. Pubmed Central PMCID: PMC2684498. Epub 2009/05/22.eng. .

  56. Reese RM, Dourado M, Anderson K, Warming S, Stark KL, Balestrini A, Suto E, Lee W, Riol-Blanco L, Shields SD, Hackos DH. Behavioral characterization of a CRIS-PR-generated TRPA1 knockout rat in models of pain, itch, and asthma. Sci Rep. 2020;10(1):979. .

  57. Chen J, Hackos DH. TRPA1 as a drug target-promise and challenges. Naunyn Schmiedebergs Arch Pharmacol. 2015;388(4):451-63. PubMed PMID: 25640188. Pubmed Central PMCID: PMC4359712. Epub 2015/02/03. eng. .

  58. Sharma N, Tripathi P, Awasthi S. Role of ADAM33 gene and associated single nucleotide polymorphisms in asthma. Allergy Rhinol (Providence). 2011;2(2):e63-70. PubMed PMID: 22852121.eng. .

  59. Wang M, Xing ZM, Lu C, Ma YX, Yu DL, Yan Z, Wang, SW, Yu LS. A common IL-13 Arg130Gln single nucleotide polymorphism among Chinese atopy patients with allergic rhinitis. Hum Genet. 2003;113(5):387-90. PubMed PMID: 12928861. .

  60. Hwang KC, Wang JY, Hsieh KH. Increased erythrocyte adenosine deaminase activity in asthmatic children. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1990;31(2):76-80. PubMed PMID: 2275369. Epub 1990/03/01.eng. .

  61. Lloyd CM, Hawrylowicz CM. Regulatory T cells in asthma. Immunity. 2009;31(3):438-49. PubMed PMID: 19766086.eng. .

  62. Robinson DS. Regulatory T cells and asthma. Clin Exp Allergy. 2009;39(9):1314-23. PubMed PMID: 19538496. Epub 2009/06/23.eng. .

  63. Chen T, Hou X, Ni Y, Du W, Han H, Yu Y, Shi G. The imbalance of FOXP3/GATA3 in regulatory T cells from the peripheral blood of asthmatic patients. J Immunol Res. 2018;2018:3096183. PubMed PMID: 30013989. Pubmed Central PMCID: PMC6022336. .

  64. Okada M, Kanamori M, Someya K, Nakatsukasa H, Yoshimura A. Stabilization of Foxp3 expression by CRIS-PR-dCas9-based epigenome editing in mouse primary T cells. Epigenetics Chromatin. 2017;10:24. PubMed PMID: 28503202.eng. .

  65. Ahmed MS, Dutta RK, Manandhar P, Li X, Torabi H, Barrios A, Wang P, Chinnapaiyan S, Unwalla HJ, Moon JH. A guanylurea-functionalized conjugated polymer enables RNA interference in ex vivo human airway epithelium. Chem Commun (Camb). 2019;55(54):7804-7. .

  66. Krishnamurthy S, Wohlford-Lenane C, Kandimalla S, Sartre G, Meyerholz DK, Theberge V, Hallee S, Duperre AM, Del'Guidice T, Lepetit-Stoffaes JP, Barbeau X, Guay D, McCray PB Jr. Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia. Nat Commun. 2019;10(1):4906. .

CITADO POR
  1. Bolboli Zade Pedram, Farahani Abbas, Riyahi Mohammadreza, Lalabadi Ali, Salimi Asl Ali, Montazerghaem Sobhan, A Literature Review on Hospital-Acquired Pneumonia, Community-Acquired Pneumonia, and Ventilator-Associated Pneumonia, Gene, Cell and Tissue, 9, 2, 2021. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain